| Source NDC Code |
|
Target HCPCS Code |
00069-1109-02
PANZYGA 10% (2.5 G/25 ML) V
|
⇄
|
90283
Immune globulin (IGIV), human, for intravenous use
|
| Detail Information |
| Relationship Start Date |
11/26/2018 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00069-1109-02
PANZYGA (PF,LATEX-FREE) 100 MG/1 ML
|
⇄
|
J1576
INJECTION, IMMUNE GLOBULIN (PANZYGA), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG
|
| Detail Information |
| Relationship Start Date |
07/01/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00069-1109-02
PANZYGA (PF,LATEX-FREE) 100 MG/1 ML
|
⇄
|
J1599
INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), NOT OTHERWISE SPECIFIED, 500 MG
|
| Detail Information |
| Relationship Start Date |
08/07/2019 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00069-1109-02
Panzyga
|
⇄
|
J1576
Inj, panzyga, 500 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|